Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in …

EO Murchu, L Comber, K Jordan… - Reviews in Medical …, 2023 - Wiley Online Library
The most effective means of preventing seasonal influenza is through vaccination. In this
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …

Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in …

L Comber, K Jordan, S Hawkshaw… - Reviews in Medical …, 2022 - europepmc.org
The most effective means of preventing seasonal influenza is through vaccination. In this
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …

Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta …

BL Coleman, R Sanderson, MDM Haag… - Influenza and other …, 2021 - Wiley Online Library
Background Standard‐dose seasonal influenza vaccines often produce modest
immunogenic responses in adults≥ 65 years old. MF59 is intended to elicit a greater …

Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals …

L Comber, EO Murchu, K Jordan… - Reviews in Medical …, 2023 - Wiley Online Library
This review sought to assess the efficacy, effectiveness and safety of high‐dose inactivated
influenza vaccines (HD‐IIV) for the prevention of laboratory‐confirmed influenza in …

[HTML][HTML] Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: a systematic review and meta …

J Yang, J Zhang, T Han, C Liu, X Li, L Yan, B Yang… - Medicine, 2020 - journals.lww.com
Background: Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …

[HTML][HTML] Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults …

A Poder, J Oberije, J Meyer, P Heymer, D Molrine… - Vaccines, 2023 - mdpi.com
Adults aged 50–64 years have a high incidence of symptomatic influenza associated with
substantial disease and economic burden each year. We conducted a randomized …

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database

M Pellegrini, U Nicolay, K Lindert, N Groth… - Vaccine, 2009 - Elsevier
BACKGROUND: Adding adjuvants such as MF59® to influenza vaccines can enhance the
immune response. This analysis evaluated the safety profile of MF59-adjuvanted [(+) MF59] …

[HTML][HTML] Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis

S Minozzi, T Lytras, S Gianola… - …, 2022 - thelancet.com
Background Influenza is one of the most common respiratory viral infections worldwide.
Numerous vaccines are used to prevent influenza. Their selection should be informed by the …

[HTML][HTML] Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older

K Lindert, B Leav, E Heijnen, J Barrett… - International Journal of …, 2019 - Elsevier
Objective To assess the long-term safety of MF59-adjuvanted trivalent influenza vaccine
(aIIV3; Fluad™) in adults≥ 65 years of age. Methods Data from 36 primary vaccination and …

Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory‐confirmed …

EO Murchu, L Comber, K Jordan… - Reviews in Medical …, 2023 - Wiley Online Library
The most effective means of preventing seasonal influenza is through vaccination. In this
systematic review, we investigated the efficacy, effectiveness and safety of recombinant …